Three-dimensional structure of staphylokinase, a plasminogen activator with therapeutic potential
about
Pro42 and Val45 of staphylokinase modulate intermolecular interactions of His43-Tyr44 pair and specificity of staphylokinase-plasmin activator complexThe ternary microplasmin-staphylokinase-microplasmin complex is a proteinase-cofactor-substrate complex in actionCharacterization of a novel bifunctional mutant of staphylokinase with platelet-targeted thrombolysis and antiplatelet aggregation activitiesNecessity of high-resolution for coarse-grained modeling of flexible proteins.Small but versatile: the extraordinary functional and structural diversity of the beta-grasp foldAntimicrobial Peptide Resistance Mechanisms of Gram-Positive Bacteria.Psychosocial risk factors of myocardial infarction and adverse effects of streptokinase in public sector hospitalsBacterial plasminogen receptors utilize host plasminogen system for effective invasion and dissemination.Structural basis for reduced staphylocoagulase-mediated bovine prothrombin activationThe natural history of ubiquitin and ubiquitin-related domains.NH2-terminal structural motifs in staphylokinase required for plasminogen activation.Staphylokinase as a plasminogen activator component in recombinant fusion proteins.Quantitative Real-Time PCR technique for the identification of E.coli residual DNA in streptokinase recombinant product.Staphylokinase has distinct modes of interaction with antimicrobial peptides, modulating its plasminogen-activation properties.Structure-based redesign of proteins for minimal T-cell epitope contentFunction of the 90-loop (Thr90-Glu100) region of staphylokinase in plasminogen activation probed through site-directed mutagenesis and loop deletion.Structure-based antigenic epitope and PEGylation improve the efficacy of staphylokinase.
P2860
Q24304969-EC7A9DC8-F366-4735-B8D3-52E7F1B44837Q27765730-0F99B36A-9D9A-4A42-915C-03D3F7441E27Q28222482-E990796A-E122-49A5-AD33-E351CCCF989BQ30387498-066DDD37-38AF-4237-9829-5BF5BF751748Q33289671-7E308D99-D86E-40D7-BAD8-83FB2E336A67Q34549813-0A653712-9A16-4465-8A20-8AB361406285Q36111030-EEF6292F-1636-4BF8-B555-957FC3941D3AQ36337574-C388C763-B2D1-4396-BE7E-2C8A9D1AA31AQ36538515-68F47E8A-616A-42C6-937E-27FA0058F1C4Q37971572-4467322A-1E76-4276-BDCD-18459D0436B2Q38334202-4AB3C053-BBB1-4233-BF63-1B543B3AC506Q39480311-6B239F32-0F0A-4B16-A474-5BC4C0FF77D2Q40063461-B4692A30-F61B-4C4B-ACE8-62AF220EBB48Q41330788-59FCDA11-8960-41EF-BC2C-320D931DB9C5Q41988381-32904B76-0374-4A58-8FE8-88041136397DQ42932424-EB16AEC7-6A82-469E-8BCC-B3B7B911E954Q47128548-2983C332-1FEC-4F67-AC0C-EE48E35118E2
P2860
Three-dimensional structure of staphylokinase, a plasminogen activator with therapeutic potential
description
1997 nî lūn-bûn
@nan
1997 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Three-dimensional structure of ...... tor with therapeutic potential
@ast
Three-dimensional structure of ...... tor with therapeutic potential
@en
Three-dimensional structure of ...... tor with therapeutic potential
@nl
type
label
Three-dimensional structure of ...... tor with therapeutic potential
@ast
Three-dimensional structure of ...... tor with therapeutic potential
@en
Three-dimensional structure of ...... tor with therapeutic potential
@nl
prefLabel
Three-dimensional structure of ...... tor with therapeutic potential
@ast
Three-dimensional structure of ...... tor with therapeutic potential
@en
Three-dimensional structure of ...... tor with therapeutic potential
@nl
P2093
P2860
P3181
P356
P1476
Three-dimensional structure of ...... tor with therapeutic potential
@en
P2093
C De Ranter
H L De Bondt
P2860
P304
P3181
P356
10.1038/NSB0597-357
P577
1997-05-01T00:00:00Z